Copyright © 1992 by the European Society of Cardiology.
© 1992 The European Society of Cardiology
Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure
Department of Cardiology, University Hospital Eppendorf Hamburg, Germany
Received 8 April 1991; revised 3 January 1992; .
Correspondence: Dr H.-H. Erlemeier, Cardiologist, Ochsenzoller Str, 201, D-2000 Norderstedl, Germany
Abstract
Twenty patients (two female, 18 male, mean age 57±11 years) with severe heart failure NYHA IV (7 coronary artery disease, 13 congestive cardiomyopathy) were treated with 8·8±l·7µg .kg1. min1 of dobutamine. Pulmonary gas exchange was analysed by withdrawal of blood samples from a central venous catheter and a radial artery canula.
Dobutamine increased SvO2 from 58·7±11·2% to 72·2±6·3% (P=0·0001) and decreased avDO2 from 7·7±2·45 Vol% to 4·97±1·34 Vol% (P=0·0001). PaO2 and PaCO2 were not changed. Qs/Qt increased slightly from 91±8·3% to 11·3±6·4% (P=0·035). Cardiac index increased by 51% (P=0·0001), pulmonary capillary wedge pressure decreased by 28% (P=0·0001). In patients with severe heart failure, dobutamine improved haemodynamics without detrimental effects on arterial oxygen concentration.
Key Words: Dobutamine pulmonary gas exchange
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Opasich, A. Russo, R. Mingrone, M. Zambelli, and L. Tavazzi Intravenous inotropic agents in the intensive therapy unit: do they really make a difference? Eur J Heart Fail, March 1, 2000; 2(1): 7 - 11. [Abstract] [Full Text] [PDF] |
||||
